Cognizant (CTSH) Tops Q2 EPS by 11c; offers guidance

Cognizant (NASDAQ: CTSH) reported Q2 EPS of $1.10, $0.11 better than the analyst estimate of $0.99. Revenue for the quarter came in at $4.9 billion versus the consensus estimate of $4.84 billion.

GUIDANCE:

Cognizant sees Q3 2023 revenue of $4.89-4.94 billion, versus the consensus of $4.863 billion.

Cognizant sees FY2023 EPS of $4.25-$4.48, versus the consensus of $4.28. Cognizant sees FY2023 revenue of $19.2-19.6 billion, versus the consensus of $19.454 billion.

For earnings history and earnings-related data on Cognizant (CTSH) click here.

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• Bragg Gaming Group Inc. (BRAG) Tops Q2 EPS by 2c
• Ascendis Pharma (ASND) Tops Q2 EPS by 132c